Junko Yoshida
Department of Pharmacology
Kanazawa Medical University
Uchinada
Ishikawa
Japan
Name/email consistency: low
- Amlodipine, a Ca2+ channel blocker, suppresses phosphorylation of epidermal growth factor receptor in human epidermoid carcinoma A431 cells. Yoshida, J., Ishibashi, T., Yang, M., Nishio, M. Life Sci. (2010)
- G1 cell cycle arrest by amlodipine, a dihydropyridine Ca2+ channel blocker, in human epidermoid carcinoma A431 cells. Yoshida, J., Ishibashi, T., Nishio, M. Biochem. Pharmacol. (2007)
- Capacitative Ca2+ entries and mRNA expression for TRPC1 and TRPC5 channels in human epidermoid carcinoma A431 cells. Yoshida, J., Ishibashi, T., Imaizumi, N., Takegami, T., Nishio, M. Eur. J. Pharmacol. (2005)
- Antitumor effects of amlodipine, a Ca2+ channel blocker, on human epidermoid carcinoma A431 cells in vitro and in vivo. Yoshida, J., Ishibashi, T., Nishio, M. Eur. J. Pharmacol. (2004)
- Growth-inhibitory effect of a streptococcal antitumor glycoprotein on human epidermoid carcinoma A431 cells: involvement of dephosphorylation of epidermal growth factor receptor. Yoshida, J., Ishibashi, T., Nishio, M. Cancer Res. (2001)
- Characterization of a streptococcal antitumor glycoprotein (SAGP). Yoshida, J., Takamura, S., Nishio, M. Life Sci. (1998)